147 related articles for article (PubMed ID: 9395317)
1. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
[TBL] [Abstract][Full Text] [Related]
3. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
[TBL] [Abstract][Full Text] [Related]
4. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
[TBL] [Abstract][Full Text] [Related]
5. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lipid-binding and lecithin:cholesterol acyltransferase activation of the amino- and carboxyl-terminal domains of human apolipoprotein E3.
De Pauw M; Vanloo B; Weisgraber K; Rosseneu M
Biochemistry; 1995 Aug; 34(34):10953-66. PubMed ID: 7662677
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the hydrophobicity gradient to the secondary structure and activity of fusogenic peptides.
Decout A; Labeur C; Vanloo B; Goethals M; Vandekerckhove J; Brasseur R; Rosseneu M
Mol Membr Biol; 1999; 16(3):237-46. PubMed ID: 10503245
[TBL] [Abstract][Full Text] [Related]
8. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation.
Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW; Landrum M
J Biol Chem; 1998 May; 273(19):11776-82. PubMed ID: 9565601
[TBL] [Abstract][Full Text] [Related]
9. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
[TBL] [Abstract][Full Text] [Related]
10. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
[TBL] [Abstract][Full Text] [Related]
11. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.
Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F
J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363
[TBL] [Abstract][Full Text] [Related]
12. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
[TBL] [Abstract][Full Text] [Related]
13. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
[TBL] [Abstract][Full Text] [Related]
14. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
[TBL] [Abstract][Full Text] [Related]
15. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
Johnson JE; Rao NM; Hui SW; Cornell RB
Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
[TBL] [Abstract][Full Text] [Related]
16. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity.
Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW
J Biol Chem; 1997 Mar; 272(11):7278-84. PubMed ID: 9054424
[TBL] [Abstract][Full Text] [Related]
17. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation.
Emmanuel F; Steinmetz A; Rosseneu M; Brasseur R; Gosselet N; Attenot F; Cuiné S; Séguret S; Latta M; Fruchart JC
J Biol Chem; 1994 Nov; 269(47):29883-90. PubMed ID: 7961983
[TBL] [Abstract][Full Text] [Related]
18. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.
Buchko GW; Treleaven WD; Dunne SJ; Tracey AS; Cushley RJ
J Biol Chem; 1996 Feb; 271(6):3039-45. PubMed ID: 8621698
[TBL] [Abstract][Full Text] [Related]
20. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
